Betulinic acid exhibits antiviral effects against dengue virus infection
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 184, 104954
Abstract
No abstract availableKeywords
Funding Information
- Guangxi University of Chinese Medicine
- National University of Singapore
This publication has 24 references indexed in Scilit:
- Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled TrialClinical Infectious Diseases, 2012
- Flacourtosides A–F, Phenolic Glycosides Isolated from Flacourtia ramontchiJournal of Natural Products, 2012
- Natural Products and Traditional Medicine: Turning on a ParadigmJournal of Natural Products, 2012
- Dengue: a continuing global threatNature Reviews Microbiology, 2010
- Characterization of Dengue Virus Resistance to Brequinar in Cell CultureAntimicrobial Agents and Chemotherapy, 2010
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese AdultsPLOS Neglected Tropical Diseases, 2010
- Betulinic Acid Derivatives as Human Immunodeficiency Virus Type 2 (HIV-2) InhibitorsJournal of Medicinal Chemistry, 2009
- DengueThe Lancet, 2007
- Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infectionMedicinal Research Reviews, 2003
- A New Strategy in Design of (+)RNA Virus Infectious Clones Enabling Their Stable Propagation in E. coliVirology, 2001